Literature DB >> 16388150

Scoring system for empyema thoracis and help in management.

K S Wong1, T Y Lin, Y C Huang, L Y Chang, S H Lai.   

Abstract

OBJECTIVE: To evaluate the implications of a newly defined severity scoring of empyema in children for the prediction of surgical management and to compare the length of hospitalization as an outcome measure of patients treated using medical therapy, salvage video-assisted thoracoscopic surgery (VATS) vs early elective VATS.
METHODS: A retrospective chart review of parapneumonic empyema of patients below 18 years of age admitted to a tertiary children's hospital in northern Taiwan from April 1993 to December 2002 was performed. Patients were categorized into a medical group who received antibiotic therapy, needle aspirations with/without tube thoracostomy; a salvage VATS group when the patients required surgery for the relief of persistent fever > 38 degrees C, chest pains or dyspneic respirations despite initial medical therapy; an early VATS group when the patients received elective surgery early after admission. The demographic data, clinical features, laboratory findings, and duration of hospitalization were compared using a severity score of empyema (SSE).
RESULTS: Streptococcus pneumoniae was the most common infecting organism, followed by Staphylococcus aureus, Pseudomonas aeruginosa. No organisms were recovered in 39% of patients. A pleural pH < 7.1 increases the odds of requiring surgical intervention by 6 times among this cohort. Children who required decortication of empyema had a higher severity score (mean 4.8 vs 3.0, p < 0.005). The duration of hospitalization for patients having early VATS showed a shortening stay (mean 18 vs 28 days) as compared to salvage VATS.
CONCLUSION: A pleural pH < 7.1 and a newly designed clinical severity score of empyema 4 are two predictors of surgical intervention for fibrinopurulent empyema in the present study. Early elective VATS may be adopted not later than 7 days after failure of appropriate antibiotic therapy and adequate drainage of empyema to decrease the length of stay and minimize morbidity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16388150     DOI: 10.1007/BF02724404

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  14 in total

1.  Surgical treatment of parapneumonic empyema.

Authors:  G A Khakoo; P Goldstraw; D M Hansell; A Bush
Journal:  Pediatr Pulmonol       Date:  1996-12

2.  Community-acquired pneumonia in adults in British hospitals in 1982-1983: a survey of aetiology, mortality, prognostic factors and outcome. The British Thoracic Society and the Public Health Laboratory Service.

Authors: 
Journal:  Q J Med       Date:  1987-03

3.  Management of empyema in children.

Authors:  E S Golladay; C W Wagner
Journal:  Am J Surg       Date:  1989-12       Impact factor: 2.565

4.  Implications of early sonographic evaluation of parapneumonic effusions in children with pneumonia.

Authors:  R R Ramnath; R M Heller; T Ben-Ami; M A Miller; P Campbell; W W Neblett; G W Holcomb; M Hernanz-Schulman
Journal:  Pediatrics       Date:  1998-01       Impact factor: 7.124

5.  Necrotising pneumonitis in children.

Authors:  K S Wong; C H Chiu; K M Yeow; Y C Huang; H P Liu; T Y Lin
Journal:  Eur J Pediatr       Date:  2000-09       Impact factor: 3.183

6.  Image-guided percutaneous drainage of thoracic empyema: can sonography predict the outcome?

Authors:  S Shankar; M Gulati; M Kang; S Gupta; S Suri
Journal:  Eur Radiol       Date:  2000       Impact factor: 5.315

7.  Sonographic septation: a useful prognostic indicator of acute thoracic empyema.

Authors:  K Y Chen; Y S Liaw; H C Wang; K T Luh; P C Yang
Journal:  J Ultrasound Med       Date:  2000-12       Impact factor: 2.153

8.  Decortication for childhood empyema. The primary provider's peccadillo.

Authors:  A S Kennedy; M Agness; L Bailey; J J White
Journal:  Arch Surg       Date:  1991-10

9.  Severe community-acquired pneumonia. Epidemiology and prognostic factors.

Authors:  A Torres; J Serra-Batlles; A Ferrer; P Jiménez; R Celis; E Cobo; R Rodriguez-Roisin
Journal:  Am Rev Respir Dis       Date:  1991-08

10.  Intrapleural streptokinase as adjunctive treatment for persistent empyema in pediatric patients.

Authors:  H Rosen; V Nadkarni; M Theroux; R Padman; J Klein
Journal:  Chest       Date:  1993-04       Impact factor: 9.410

View more
  7 in total

1.  Complications and treatment failures of video-assisted thoracoscopic debridement for pediatric empyema.

Authors:  Andreas H Meier; Clayton B Hess; Robert E Cilley
Journal:  Pediatr Surg Int       Date:  2010-02-11       Impact factor: 1.827

2.  Empyema thoracis: Surgical management in children.

Authors:  Prema Menon; Ravi Prakash Kanojia; K L N Rao
Journal:  J Indian Assoc Pediatr Surg       Date:  2009-07

3.  Clinical outcome of parapneumonic empyema in children treated according to a standardized medical treatment.

Authors:  Marijke Proesmans; Brenda Gijsens; Patricia Van de Wijdeven; Herbert De Caluwe; Jan Verhaegen; Katrien Lagrou; Ellen Van Even; Francois Vermeulen; Kris De Boeck
Journal:  Eur J Pediatr       Date:  2014-05-17       Impact factor: 3.183

4.  Empyema Thoracis in Children: A 5-Year Experience in a Tertiary Care Institute.

Authors:  Kartik Chandra Mandal; Gobinda Mandal; Pankaj Halder; Dipanwita Mitra; Bidyut Debnath; Mala Bhattacharya
Journal:  J Indian Assoc Pediatr Surg       Date:  2019 Jul-Sep

5.  Surgical management of complicated parapneumonic pleural effusion in children.

Authors:  Anca Budusan; Ioan Paraian; Doina Zamora
Journal:  Clujul Med       Date:  2013-08-05

6.  Is open decortication superior to fibrinolytic therapy as a first line treatment in the management of pleural empyema?

Authors:  Sultan Ahmed; Hammad Azam; Imran Basheer
Journal:  Pak J Med Sci       Date:  2016 Mar-Apr       Impact factor: 1.088

7.  Surgical management of stage III pediatric empyema thoracis.

Authors:  Aditya Pratap Singh; Arvind Kumar Shukla; Pramila Sharma; Jyotsna Shukla
Journal:  Lung India       Date:  2018 May-Jun
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.